Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo.

Pam Belluck
Author: Pam Belluck

Written by

Pam Belluck

in

Clinical Trials, Corporations, Drugs (Pharmaceuticals), Suits and Litigation (Civil)
←A Racially Biased Test That Prevented Thousands Of Black People From Receiving Kidney Transplants Is Finally Changing
Reworked Italian Jerseys That Celebrate Soccer Style→

More posts

  • Pure Joy: Photographer Laylah Amatullah Barrayn Captures Her First ESSENCE Festival Of Culture

  • Angry crowd confronts Republican Rep. Mike Flood at Nebraska town hall

  • Rhea Seehorn celebrates her ‘Pluribus’ Emmy nomination as she waits to hear about Carol and the atom bomb

  • Emmy Nominations Analysis: ‘The Pitt’ And ‘Hacks’ Dominance Proves It Helps To Be On A Show Voters Actually Watch

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube